Logo

Biocartis: George Cardoza

Jul 19, 2023

Biocartis named George Cardoza as its new CFO and head of service delivery effective August 7. Cardoza will be responsible for overseeing the company's financial strategies and strategic partnerships, and for ensuring sustainable growth. Cardoza previously served as CEO of AccuraGen Holdings, an NGS-based liquid biopsy test developer. He has also served as president and chief operating officer for laboratory sciences, and as CFO at NeoGenomics Laboratories.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.